Phase II study of S-1-based sequential combination chemotherapy including oxaliplatin plus bevacizumab and irinotecan with or without cetuximab for metastatic colorectal cancer: the SOBIC trial

Phase Ii ◽

Phase Ii Study ◽

Sequential Combination

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1425-7 ◽

2010 ◽

Vol 67 (6) ◽

pp. 1323-1331 ◽

Cited By ~ 22

Author(s):

Junshik Hong ◽

Sae-Won Han ◽

Hye Seon Ham ◽

Tae-Yong Kim ◽

In Sil Choi ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study

Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS

Investigational New Drugs ◽

10.1007/s10637-009-9382-x ◽

2010 ◽

Vol 29 (4) ◽

pp. 688-693 ◽

Cited By ~ 10

Author(s):

Kohei Shitara ◽

Tomoya Yokota ◽

Daisuke Takahari ◽

Takashi Shibata ◽

Takashi Ura ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Wild Type

A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study)

Oncology ◽

10.1159/000446372 ◽

2016 ◽

Vol 91 (1) ◽

pp. 24-30 ◽

Cited By ~ 8

Author(s):

Motoki Yoshida ◽

Akinori Takagane ◽

Yasuhiro Miyake ◽

Ken Shimada ◽

Naoki Nagata ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Third Line

Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy

Investigational New Drugs ◽

10.1007/s10637-012-9853-3 ◽

2012 ◽

Vol 31 (1) ◽

pp. 183-191 ◽

Cited By ~ 4

Author(s):

Yong Sang Hong ◽

Jeeyun Lee ◽

Kyu-pyo Kim ◽

Jae-Lyun Lee ◽

Young Suk Park ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

Multicenter Phase

Phase II Study of Combination Chemotherapy with Biweekly Cetuximab and Irinotecan for Pre-treated Metastatic Colorectal Cancer Harboring Wild-type KRAS

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyq026 ◽

2010 ◽

Vol 40 (7) ◽

pp. 699-701 ◽

Cited By ~ 1

Author(s):

K. Shitara ◽

T. Yokota ◽

D. Takahari ◽

T. Shibata ◽

T. Ura ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Wild Type

Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines

Investigational New Drugs ◽

10.1007/s10637-010-9615-z ◽

2010 ◽

Vol 30 (2) ◽

pp. 787-793 ◽

Cited By ~ 11

Author(s):

Kohei Shitara ◽

Satoshi Yuki ◽

Motoki Yoshida ◽

Daisuke Takahari ◽

Setsuo Utsunomiya ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Wild Type

P-0239 Capecitabine and Oxaliplatin (XELOX) Combination Chemotherapy as First-Line Treatment for Metastatic Colorectal Cancer- A Phase II Study

Annals of Oncology ◽

10.1016/s0923-7534(20)30166-6 ◽

2012 ◽

Vol 23 ◽

pp. iv98

Author(s):

Hesham Tawfik ◽

HananGamal El-Deen

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First Line Treatment

A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.13511 ◽

2021 ◽

Author(s):

Mingzhu Huang ◽

Yue Yang ◽

Xiaodong Zhu ◽

Zhiyu Chen ◽

Wen Zhang ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Salvage Treatment ◽

Prospective Phase

Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(88)90321-5 ◽

1988 ◽

Vol 24 (4) ◽

pp. 801-802 ◽

Cited By ~ 8

Author(s):

Janke Greidanus ◽

Pax H.B. Willemse ◽

Dirk Th. Sleijfer ◽

Nanno H. Mulder ◽

RenéC.J. Verschueren ◽

...

Keyword(s):

Colorectal Cancer ◽

Continuous Infusion ◽

Phase Ii ◽

Phase Ii Study ◽

Infusion Schedule

Phase II Study of Recombinant Antitumor and Antivirus Protein Injection Compared With Placebo in Metastatic Colorectal Cancer After Failure of Standard Treatment

The Oncologist ◽

10.1634/theoncologist.2014-0439 ◽

2015 ◽

Vol 20 (6) ◽

pp. 619-620

Author(s):

Ru Jia ◽

Yan Wang ◽

Xiao‐Yang Mao ◽

Shan‐Shan Li ◽

Nong Xu ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Standard Treatment ◽

Phase Ii Study